A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Clinical trial NCT06385080 · RECRUITING
Trial details
- NCT number
- NCT06385080
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-22
- Primary completion
- 2032-12-27
- Enrollment
- 287
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.